Roche INFECTIOUS DISEASE AWARD 2022に選ばれました

Roche INFECTIOUS DISEASE AWARD 2022に選ばれました

Roche INFECTIOUS DISEASE AWARD 2022に選ばれました2023.01.24

当科で行ったCOVID-19に関わる下記研究がRoche INFECTIOUS DISEASE AWARD 2022に選ばれました。
・優秀賞
蛯原健特任助教
①Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis (Frontiers in immunology, (2021).798338)
②Combination of WFDC2, CHI3L1 and KRT19 in plasma defines a clinically useful molecular phenotype associated with prognosis in critically ill COVID-19 patients(J Clin Immunol. 2022 Nov 4. Epub ahead of print)
・入選
戸上由貴医師(大学院博士課程)
Significance of interferon signaling based on mRNA-microRNA integration and plasma protein analyses in critically ill COVID-19 patients (Molecular Therapy Nucleic Acids. Volume 29, (2022), Pages 343-353)